Comprehensive molecular and clinical findings in 29 patients with multi-locus imprinting disturbance

Tatsuki Urakawa1,2, Hidenobu Soejima3, Kaori Yamoto4

  • 1Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, 157-8535, Japan.

Clinical Epigenetics
|October 5, 2024
PubMed
Abstract

Insights

Multi-locus imprinting disturbance (MLID) affects 7.5% of imprinting disorder cases with epimutation. This study found diverse methylation defects, genetic variants, and neurodevelopmental issues in MLID patients, with a higher incidence in those conceived via assisted reproductive technology.

Area of Science:

  • Genetics
  • Epigenetics
  • Developmental Biology

Background:

  • Multi-locus imprinting disturbance (MLID) involves methylation defects in differentially methylated regions (DMRs) and is linked to imprinting disorders (IDs).
  • Deleterious variants in methylation maintenance genes, including those for the subcortical maternal complex (SCMC), have been implicated in a subset of ID patients.
  • Previous integrated analyses of DMR methylation and causative gene sequencing in MLID cases and their mothers were limited.

Purpose of the Study:

  • To investigate the prevalence and characteristics of MLID in a large cohort of patients with imprinting disorders.
  • To perform integrated methylation and sequence analysis in MLID patients and their mothers to identify causative genetic and epigenetic factors.
  • To explore clinical features, including neurodevelopmental outcomes, and associations with assisted reproductive technology (ART) in MLID patients.

Main Methods:

  • Methylation analysis of multiple ID-associated DMRs using pyrosequencing and/or methylation-specific multiple ligation-dependent probe amplification (MS-MLPA) in 386 patients with confirmed epimutation.
  • Array-based methylation analysis of 78 DMRs and whole-exome sequencing in 29 identified MLID patients.
  • Clinical data collection, including neurodevelopmental assessment and ART conception history.

Main Results:

  • MLID was identified in 29 patients (7.5% of 386 with epimutation), primarily in those with Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syndrome (SRS) phenotypes.
  • All MLID patients exhibited hypomethylation-dominant aberrant methylation patterns in various DMRs.
  • Nine deleterious variants were found in SCMC-related genes (eight in mothers, one in a patient), and neurodevelopmental delay/intellectual developmental disorder (ND/IDD) was observed in about half of MLID patients.
  • A notable proportion of BWS patients with MLID were conceived via ART.

Conclusions:

  • MLID represents a significant cause of imprinting disorders, occurring in 7.5% of epimutation cases.
  • The study highlights diverse hypomethylation-dominant methylation defects and identifies potential deleterious variants in MLID.
  • Neurodevelopmental complications are common in MLID patients, and a higher frequency of MLID is observed in ART-conceived individuals.